高级搜索
表现为磨玻璃样病变的肺腺癌临床特点与EGFR及K-RAS基因突变的关系[J]. 肿瘤防治研究, 2014, 41(12): 1313-1317. DOI: 10.3971/j.issn.1000-8578.2014.12.013
引用本文: 表现为磨玻璃样病变的肺腺癌临床特点与EGFR及K-RAS基因突变的关系[J]. 肿瘤防治研究, 2014, 41(12): 1313-1317. DOI: 10.3971/j.issn.1000-8578.2014.12.013
Relationship of Clinical Characteristics and EGFR, K-RAS Mutation in Lung Adenocarcinoma Patients with Predominant Ground-glass Opacity[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1313-1317. DOI: 10.3971/j.issn.1000-8578.2014.12.013
Citation: Relationship of Clinical Characteristics and EGFR, K-RAS Mutation in Lung Adenocarcinoma Patients with Predominant Ground-glass Opacity[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1313-1317. DOI: 10.3971/j.issn.1000-8578.2014.12.013

表现为磨玻璃样病变的肺腺癌临床特点与EGFR及K-RAS基因突变的关系

Relationship of Clinical Characteristics and EGFR, K-RAS Mutation in Lung Adenocarcinoma Patients with Predominant Ground-glass Opacity

  • 摘要: 目的 探讨表现为磨玻璃样病变(GGO)的肺腺癌的临床特点与EGFR及K-RAS基因突变关系。方法 连续选择37例经胸腔镜手术及病理证实为肺腺癌的肺GGO病例,分析其临床特点,检测EGFR与K-RAS基因突变情况,及与各临床因素之间的关系。结果 34例行肺叶切除术,3例行肺楔形切除术,术后病理结果显示:16例为原位腺癌,13例为微浸润腺癌,8例为浸润性腺癌。EGFR 基因突变22例,K-RAS基因突变1例;在单纯型GGO及混合型GGO病例中,EGFR与K-RAS基因突变均无明显差异;在女性、不吸烟病例中EGFR基因突变相较男性及吸烟病例差异具有统计学意义(P<0.05)。结论 EGFR基因在表现为GGO的肺腺癌病例中表现出较高的突变率,为肺GGO病例临床治疗提供了重要参考。

     

    Abstract: Objective To investigate the relationship between clinical characteristics and EGFR, K-RAS mutation in 37 lung adenocarcinoma patients with predominant ground-glass opacity(GGO). Methods We reviewed the records of 37 lung adenocarcinoma patients with GGO diagnosed by thoracoscopy surgery and postoperative pathology. We analyzed the clinical characteristics and EGFR, K-RAS genic mutation and examined their relationship. Results Among the 37 patients, 34 patients received lobectomy, and the other 3 patients underwent wedge resection of lung. Postoperative pathological diagnosis result was 16 cases of adenocarcinoma in situ (AIS), 13 cases of micro-infiltrating adenocarcinoma(MIA)and 8 cases of infiltrating adenocarcinoma. EGFR mutation was present in 22 cases and K-RAS mutation was observed in one case. There was no significant difference in EGFR and K-RAS mutation between of pGGO cases and mGGO cases, while EGFR mutation were more common in non-smokers and female(P<0.05). Conclusion Lung adenocarcinoma with dominant GGO possess higher EGFR mutations, which could provide definite important reference for clinical molecular targeted therapy for lung GGO patients.

     

/

返回文章
返回